New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly

byThe Mount Sinai HospitalFor the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a reoccurrence of lethal,

Updated on: December 18,2023 10

New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly

byThe Mount Sinai HospitalFor the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a reoccurrence of lethal,

Updated on:December 18,2023 10

Trial demonstrates acute lymphoblastic leukemia treatment advance

by Diane Dragaud, ECOG-ACRIN Cancer Research GroupCredit:LBA-1 Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblas

Updated on: January 04,2024 9

Trial demonstrates acute lymphoblastic leukemia treatment advance

by Diane Dragaud, ECOG-ACRIN Cancer Research GroupCredit:LBA-1 Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblas

Updated on:January 04,2024 9

Analyzing a Study on the Therapeutic Potential of Targeting IL-20RB in Lung Cancer Bone Metastasis

Updated on: September 15,2024 0

Analyzing a Study on the Therapeutic Potential of Targeting IL-20RB in Lung Cancer Bone Metastasis

Updated on:September 15,2024 0

New therapeutic approach for the treatment of sarcoidosis

by Medical University of ViennaImmunofluorescence staining makes granulomas glow red with a green border (macrophages with fibroblasts). Credit: MedUni Vienna/Anna RedlA research team led by Geor

Updated on: April 02,2024 13

New therapeutic approach for the treatment of sarcoidosis

by Medical University of ViennaImmunofluorescence staining makes granulomas glow red with a green border (macrophages with fibroblasts). Credit: MedUni Vienna/Anna RedlA research team led by Geor

Updated on:April 02,2024 13

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t

Updated on: December 17,2023 12

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t

Updated on:December 17,2023 12

Half the amount of chemo prevents testicular cancer from coming back, new trial shows

byInstitute of Cancer ResearchMicrograph of seminoma testes showing lobules of uniform cells separated by delicate septae of fibrous tissue. Credit: Calicut Medical College via Wikimedia. Licens

Updated on: December 22,2023 23

Half the amount of chemo prevents testicular cancer from coming back, new trial shows

byInstitute of Cancer ResearchMicrograph of seminoma testes showing lobules of uniform cells separated by delicate septae of fibrous tissue. Credit: Calicut Medical College via Wikimedia. Licens

Updated on:December 22,2023 23

Marker found for condition that causes numerous tumors

by Cathy Frisinger,UT Southwestern Medical CenterCutaneous neurofibromas cover the back of a patient. Credit: UTSWUT Southwestern researchers have made a major advance in uncovering the biology

Updated on: December 18,2023 16

Marker found for condition that causes numerous tumors

by Cathy Frisinger,UT Southwestern Medical CenterCutaneous neurofibromas cover the back of a patient. Credit: UTSWUT Southwestern researchers have made a major advance in uncovering the biology

Updated on:December 18,2023 16

Cancers engaged in evolutionary arms race with immune system

byInstitute of Cancer ResearchMultiplex immunohistochemistry image of T-cells infiltrating stomach tumours. Credit: Katharina von Loga, Biomedical Research CentreAggressive, highly mutated cance

Updated on: December 22,2023 14

Cancers engaged in evolutionary arms race with immune system

byInstitute of Cancer ResearchMultiplex immunohistochemistry image of T-cells infiltrating stomach tumours. Credit: Katharina von Loga, Biomedical Research CentreAggressive, highly mutated cance

Updated on:December 22,2023 14

Improving drug therapy for relapsed leukemia

by Haleigh Ehmsen,Northwestern UniversityResponse rates in all FLT3mutpatients treated at any dose (n = 56) and in those who did (n = 35) or did not (n = 21) receive prior treatment with a

Updated on: December 22,2023 9

Improving drug therapy for relapsed leukemia

by Haleigh Ehmsen,Northwestern UniversityResponse rates in all FLT3mutpatients treated at any dose (n = 56) and in those who did (n = 35) or did not (n = 21) receive prior treatment with a

Updated on:December 22,2023 9

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e

Updated on: December 22,2023 18

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e

Updated on:December 22,2023 18

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor

Updated on: December 22,2023 10

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor

Updated on:December 22,2023 10

A quicker answer on cancer, with waits cut from 84 days to 6

bySwansea UniversityCredit: CC0 Public DomainA rapid diagnosis centre has cut waiting times for patients with non-specific symptoms who may have cancer from 84 days to 6, and costs less than cur

Updated on: December 22,2023 21

A quicker answer on cancer, with waits cut from 84 days to 6

bySwansea UniversityCredit: CC0 Public DomainA rapid diagnosis centre has cut waiting times for patients with non-specific symptoms who may have cancer from 84 days to 6, and costs less than cur

Updated on:December 22,2023 21